Handelsbanken Fonder AB Raises Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Handelsbanken Fonder AB boosted its position in The Cooper Companies, Inc. (NASDAQ:COO) by 14.6% during the 4th quarter, HoldingsChannel.com reports. The firm owned 627,522 shares of the medical device company’s stock after purchasing an additional 79,853 shares during the quarter. Handelsbanken Fonder AB’s holdings in Cooper Companies were worth $57,688,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the company. Ashton Thomas Securities LLC purchased a new stake in shares of Cooper Companies in the third quarter worth $25,000. Covestor Ltd increased its stake in Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after acquiring an additional 200 shares during the last quarter. Byrne Asset Management LLC purchased a new stake in shares of Cooper Companies in the 4th quarter valued at about $33,000. Brown Brothers Harriman & Co. boosted its position in shares of Cooper Companies by 191.0% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after acquiring an additional 275 shares during the last quarter. Finally, Cromwell Holdings LLC purchased a new position in shares of Cooper Companies during the third quarter worth about $52,000. 24.39% of the stock is owned by institutional investors.

Cooper Companies Trading Down 1.0 %

Shares of COO stock opened at $86.46 on Thursday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The business has a 50-day moving average of $93.23 and a 200 day moving average of $99.65. The stock has a market capitalization of $17.26 billion, a PE ratio of 44.34, a P/E/G ratio of 2.23 and a beta of 1.00. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter last year, the business earned $0.87 earnings per share. The business’s revenue was up 9.8% on a year-over-year basis. As a group, sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analyst Weigh In

COO has been the topic of a number of recent analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Wells Fargo & Company upped their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Morgan Stanley lowered their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. Finally, Citigroup cut their price objective on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a report on Friday, December 6th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.